The company provides a direct‑to‑consumer saliva kit that generates FDA‑cleared genotyping reports on ancestry, health risks, carrier status and pharmacogenetics, delivered through a secure online portal. Customers can subscribe for continuous report updates and access optional exome sequencing or clinical blood tests via a telehealth workflow, with data stored using end‑to‑end encryption.

The startup develops a diagnostic kit that utilizes prognostic testing to accurately assess the risk and progression of melanoma in patients at early AJCC Stage I and Stage II. This technology enables targeted treatment stratification and reduces unnecessary patient surveillance, ultimately alleviating psychological stress for patients and saving health authorities significant costs.

Antiverse utilizes machine learning and advanced cell line engineering to design target-specific antibody libraries for challenging drug targets, including G-protein coupled receptors and ion channels. The platform accelerates the antibody discovery process, enabling the development of functional therapeutics within six months, addressing the lengthy timelines typically associated with traditional drug development methods.

Arctoris utilizes its automated laboratory platform, Ulysses™, to enhance drug discovery by improving data quality and experimental precision across various biological disciplines. The company addresses the inefficiencies in traditional R&D processes, enabling faster progression from target validation to candidate selection for biotech and pharmaceutical partners.

Captura utilizes renewable energy to perform Direct Ocean Capture, extracting CO2 from seawater to enhance the ocean's natural carbon removal processes without additives or by-products. This technology addresses the urgent need for scalable carbon removal solutions to mitigate climate change impacts.

Congenica provides a clinical‑grade genomic interpretation platform that transforms raw NGS data into actionable variant reports for rare disease, oncology, and infectious disease. The system combines multi‑modal analysis (SNV/indel, CNV, SV, mitochondrial, mosaic, STR) with AI‑driven prioritization, automated ACMG classification, and monthly re‑analysis to keep diagnoses up‑to‑date, all within a secure, CE‑IVDR and ISO‑certified environment.

Crescendo Biologics develops targeted Humabody therapeutics that enhance T cell activation specifically within the tumor microenvironment, utilizing a proprietary transgenic mouse platform to create fully human VH domain building blocks. Their lead candidate, CB307, aims to provide prolonged anti-cancer effects in PSMA-positive solid tumors while minimizing systemic toxicity.

Curebase provides decentralized clinical research software that enables efficient data collection through electronic patient-reported outcomes (ePRO) and electronic consent (eConsent) systems. The platform enhances participant engagement and accelerates study launches while ensuring high-quality data capture across diverse clinical trials.

Guideline offers a customizable 401(k) retirement plan platform that integrates with payroll systems to streamline plan management for businesses of all sizes. By minimizing administrative fees and providing automated investment portfolios, Guideline helps companies efficiently manage employee retirement savings while reducing costs.

Provides a learning development platform that centralizes employee training by offering access to over 200 curated providers and AI-driven personalized learning pathways. It streamlines budget management with a single invoice system, eliminating the complexity of multiple provider contracts, and uses advanced analytics to align learning initiatives with business goals and track measurable outcomes.

Mirico develops Laser Dispersion Spectroscopy (LDS) technology for precise gas measurement, enabling real-time monitoring of greenhouse gas emissions, fugitive emissions, and agricultural pollutants. This technology provides accurate data to support environmental compliance and sustainability efforts in the oil and gas, agricultural, and environmental science sectors.

NanoSyrinx is developing a synthetic biology platform for the targeted intracellular delivery of biologic drugs, such as antibodies and peptides, which often struggle with bioavailability. By utilizing a novel "nanosyringe" technology, the company aims to enhance the effectiveness of these therapies by ensuring precise delivery to specific cells.

Navenio provides indoor location positioning services through a mobile app that employs sensor fusion techniques and algorithms to accurately determine user locations in environments where GPS is ineffective. This technology enables hospital care teams to efficiently navigate and coordinate care in complex indoor settings.

ONI develops super-resolution microscopy tools, including the Nanoimager and Aplo Flow, to facilitate single-molecule imaging for researchers in various fields. Their technology simplifies sample preparation and data analysis, enabling more accurate and reproducible results in studies involving lipid nanoparticles and other biological samples.

The startup has developed a peptide identification and optimization platform that utilizes peptide bead display and ribonucleic acid display technologies to discover and present novel natural peptides. This platform enables clients to efficiently identify therapeutic candidates through high-throughput affinity and functional screening, addressing the need for biologically relevant peptide leads in drug development.

The startup has developed a brain biomarker technology that utilizes magnetic resonance imaging to measure cortical disarray, providing an index of cellular circuit health in the brain. This technology enables early and differential diagnosis of cognitive diseases, particularly Alzheimer's, allowing for timely intervention and treatment.

Realized Care offers a cloud‑based care‑pathway platform that centralizes clinical workflows and enables real‑time coordination across multidisciplinary teams. The solution integrates bi‑directional HL7/FHIR APIs with major EHRs, automates task routing, and provides analytics on protocol adherence and resource utilization, all within a HIPAA‑compliant security framework. It is aimed at hospitals, health systems, and multi‑specialty clinics seeking to improve care coordination and operational efficiency.

REGENT develops and manufactures all-electric Seaglider vessels for fast, zero-emission coastal transportation. These vessels combine aircraft speed with boat convenience, operating over water on hull, hydrofoils, or wings. The service offers commuters and travelers a sustainable, high-speed alternative to congested highways and traditional air travel.

Beam develops AI-powered autonomous underwater vehicles and robotic ships to enhance the efficiency of offshore wind farm operations. Their technology addresses the challenges of subsea inspections, maintenance, and decommissioning, significantly reducing operational costs and timelines.

Tropic Biosciences develops high-performing tropical crop varieties using CRISPR gene editing and RNA interference to enhance disease resistance and reduce pesticide reliance. Their technology addresses the challenges of climate change and food security by improving the yield and resilience of staple crops like bananas, coffee, and rice.

Ultromics offers EchoGo®, an AI-powered diagnostic tool that analyzes routine echocardiograms to identify heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing actionable insights within 20 minutes. This technology addresses the challenge of underdiagnosed cardiac conditions by delivering clinically validated assessments with high sensitivity and specificity, streamlining the diagnostic process for healthcare providers.